Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06018896
PHASE2

Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

Sponsor: Fudan University

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy of vitamin C in improving the quality of life for metastatic pancreatic cancer patients who are resistant to chemotherapy.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2023-08-25

Completion Date

2026-08-15

Last Updated

2024-06-06

Healthy Volunteers

No

Interventions

DRUG

Ascorbate

For patients with baseline serum Vitamin C concentration \< 65 μmol/L, intravenous Vitamin C 10 g × 7 days, intravenous Vitamin C 4 g × 7 days, intravenous Vitamin C 2 g × 7 days, followed by continuously 900 mg/day, three times a day, orally. For patients with baseline serum Vitamin C concentration ≥ 65 μmol/L, continuously 900 mg/day, three times a day, orally.

Locations (1)

Shanghai Cancer Center

Shanghai, Shanghai Municipality, China